1 / 23

Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Clinical Challenges in the Patient With Relapsed Multiple Myeloma. Multiple Myeloma How to decide what to do at first relapse? . Early Relapsed Multiple Myeloma Carfilzomib and Pomalidomide. Relapsed Multiple Myeloma Try to use therapies for as long as they work.

snow
Download Presentation

Clinical Challenges in the Patient With Relapsed Multiple Myeloma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Challenges in the Patient With Relapsed Multiple Myeloma

  2. Multiple MyelomaHow to decide what to do at first relapse?

  3. Early Relapsed Multiple MyelomaCarfilzomib and Pomalidomide

  4. Relapsed Multiple Myeloma Try to use therapies for as long as they work.

  5. Early Relapsed Multiple MyelomaDuration of Therapy

  6. Duration of Therapy Try to treat for at least 8 cycles or to best response and not until progression.

  7. Duration of Therapy Patients with short second remission or high-risk disease should be treated continuously until progression.

  8. Early Relapsed Multiple MyelomaRole and Timing of 2nd HDT/ASCT

  9. 2nd HDT/ASCT at RelapseUse for patients who had at least 3-year remission after first HDT/ASCT, and follow by alternative maintenance therapy to what they had previously.

  10. Abbreviations

  11. Abbreviations (cont)

  12. References

  13. References (cont)

  14. References (cont)

More Related